Antibody treatment against the extra-cellular domain of E-Cadherin inhibits proliferation of another breast cancer cell line (MCF-7) by redistributing YAP from the nucleus to the cytoplasm (Kim et al., 2011). This evidence concerns the gene CDH1 and breast carcinoma.